Title Disparate genomic characteristics of patients with early-stage lung adenocarcinoma manifesting as radiological subsolid or solid lesions
Authors Li, Hao
Sun, Zewen
Li, Yanmeng
Qi, Qingyi
Huang, Haiyan
Wang, Xuan
Zhou, Jian
Liu, Ke
Yin, Ping
Wang, Zhenfan
Li, Xiao
Yang, Fan
Affiliation Peking Univ Peoples Hosp, Dept Thorac Surg, 11 Xizhimen South St, Beijing 100044, Peoples R China
Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Sch Life Sci, Beijing 100871, Peoples R China
Peking Univ, Dept Thorac Surg, Peoples Hosp, Beijing 100871, Peoples R China
Peking Univ Peoples Hosp, Dept Radiol, Beijing 100044, Peoples R China
Berry Oncol Corp, 4 Sci Pk Rd, Beijing 102206, Peoples R China
Peking Univ Peoples Hosp, Dept Cardiac Surg, Beijing 100044, Peoples R China
Keywords GROUND-GLASS OPACITY
CANCER PROGRESSION MODELS
PROGNOSTIC IMPACT
8TH EDITION
HETEROGENEITY
NODULES
CLASSIFICATION
MANAGEMENT
INFERENCE
COMPONENT
Issue Date Apr-2022
Publisher LUNG CANCER
Abstract Introduction: Early-stage lung adenocarcinoma (LUAD) manifesting as subsolid nodules (SSNs) exhibit more favorable prognosis than solid nodules (SNs). However, the genomic underpinnings behind their indolent tumor behavior remain largely unexplained.& nbsp;Methods: We identified patients with stage I invasive LUAD who underwent complete surgical resection and broad-panel next-generation sequencing (NGS). Comparative genomic profiling was then performed by radiological subtype (SSNs vs. SNs) regarding the general genomic features, driver genes, oncogenic pathways, therapeutic actionability, and evolutionary trajectory.& nbsp;Results: In total, 177 SSN-LUADs and 133 SN-LUADs were included. Compared with SNs, SSN-LUADs possessed lower somatic mutation count (P < 0.001), genomic alteration count (P = 0.002), and intra-tumor heterogeneity (P = 0.006). In terms of driver genes, SSNs harbored more EGFR mutation (77% vs. 62%), but had lower frequencies of genes such as TP53, ARID1A, PIK3CA, CDKN2A, and BRAF (FDR q < 0.1). Besides, RBM10 mutation was independently associated with SSN-LUADs in multivariate analysis (P = 0.033). Three oncogenic pathways (p53, cell cycle, PI3K) were altered with statistical significance in SNs, while only RNA splicing/processing pathway was significantly altered in SSNs (FDR q < 0.1). Also, SSNs had significantly lower number of pathway alterations (P < 0.001). Finally, SSNs and SNs showed distinct evolutionary trajectories regarding somatic mutations during early-stage LUAD progression.& nbsp;Conclusions: This study performed the first direct comparative genomic profiling in pathologic stage I invasive LUAD by radiological subtype, highlighting a less complex genomic architecture of SSNs, which might be the molecular interpretation of their indolent tumor behavior.
URI http://hdl.handle.net/20.500.11897/646436
ISSN 0169-5002
DOI 10.1016/j.lungcan.2022.02.012
Indexed SCI(E)
Appears in Collections: 人民医院
生命科学学院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.